166 related articles for article (PubMed ID: 34805295)
1. A Meta-Analysis of Growth Differentiation Factor-15 and Prognosis in Chronic Heart Failure.
Luo JW; Duan WH; Song L; Yu YQ; Shi DZ
Front Cardiovasc Med; 2021; 8():630818. PubMed ID: 34805295
[No Abstract] [Full Text] [Related]
2. Repeated measurement of growth-differentiation factor-15 in Chinese Han patients with post-myocardial infarction chronic heart failure.
Liu JX; Li YP; Liu BH; Zhao XJ; Zhang ZY; Wang JD; Jia Q; Liu CL; Gao XJ; Xu ZG; Zhang HW; Song LN; Sun ZJ; He KL
J Geriatr Cardiol; 2018 Oct; 15(10):618-627. PubMed ID: 30416510
[TBL] [Abstract][Full Text] [Related]
3. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
[TBL] [Abstract][Full Text] [Related]
4. Serum Uric Acid and Risk of Chronic Heart Failure: A Systematic Review and Meta-Analysis.
Miao L; Guo M; Pan D; Chen P; Chen Z; Gao J; Yu Y; Shi D; Du J
Front Med (Lausanne); 2021; 8():785327. PubMed ID: 34977088
[No Abstract] [Full Text] [Related]
5. Circulating GDF-15 in relation to the progression and prognosis of chronic kidney disease: A systematic review and dose-response meta-analysis.
Zhou Z; Liu H; Ju H; Chen H; Jin H; Sun M
Eur J Intern Med; 2023 Apr; 110():77-85. PubMed ID: 36740468
[TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor-15 and the risk of cardiovascular diseases and all-cause mortality: A meta-analysis of prospective studies.
Xie S; Lu L; Liu L
Clin Cardiol; 2019 May; 42(5):513-523. PubMed ID: 30697778
[TBL] [Abstract][Full Text] [Related]
7. Growth-differentiation factor 15 as a predictor of mortality in patients with heart failure: a meta-analysis.
Zeng X; Li L; Wen H; Bi Q
J Cardiovasc Med (Hagerstown); 2017 Feb; 18(2):53-59. PubMed ID: 27454651
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Serum Galectin-3 in Chronic Heart Failure: A Meta-Analysis.
Cheng Z; Cai K; Xu C; Zhan Q; Xu X; Xu D; Zeng Q
Front Cardiovasc Med; 2022; 9():783707. PubMed ID: 35252382
[TBL] [Abstract][Full Text] [Related]
9. Relationship between serum growth differentiation factor 15, fibroblast growth factor-23 and risk of atrial fibrillation: A systematic review and meta-analysis.
Tan Z; Song T; Huang S; Liu M; Ma J; Zhang J; Yu P; Liu X
Front Cardiovasc Med; 2022; 9():899667. PubMed ID: 35990956
[TBL] [Abstract][Full Text] [Related]
10. Incremental prognostic power of novel biomarkers (growth-differentiation factor-15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failure.
Lok DJ; Klip IT; Lok SI; Bruggink-André de la Porte PW; Badings E; van Wijngaarden J; Voors AA; de Boer RA; van Veldhuisen DJ; van der Meer P
Am J Cardiol; 2013 Sep; 112(6):831-7. PubMed ID: 23820571
[TBL] [Abstract][Full Text] [Related]
11. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial.
Bouabdallaoui N; Claggett B; Zile MR; McMurray JJV; O'Meara E; Packer M; Prescott MF; Swedberg K; Solomon SD; Rouleau JL;
Eur J Heart Fail; 2018 Dec; 20(12):1701-1709. PubMed ID: 30204280
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
Izumiya Y; Hanatani S; Kimura Y; Takashio S; Yamamoto E; Kusaka H; Tokitsu T; Rokutanda T; Araki S; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H
Can J Cardiol; 2014 Mar; 30(3):338-44. PubMed ID: 24484911
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of growth differentiation factor-15 in patients with coronary artery disease: A meta-analysis and systematic review.
Zhang S; Hao P; Li J; Zhang Q; Yin X; Wang J; Chen Y
Front Cardiovasc Med; 2023; 10():1054187. PubMed ID: 36844747
[TBL] [Abstract][Full Text] [Related]
15. Association between growth differentiation factor-15 and chronic heart failure in coronary atherosclerosis patients.
Zhu ZD; Sun T
Genet Mol Res; 2015 Mar; 14(1):2225-33. PubMed ID: 25867369
[TBL] [Abstract][Full Text] [Related]
16. Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis.
Taylor RS; Walker S; Ciani O; Warren F; Smart NA; Piepoli M; Davos CH
Health Technol Assess; 2019 May; 23(25):1-98. PubMed ID: 31140973
[TBL] [Abstract][Full Text] [Related]
17. Association of growth differentiation factor-15 level with adverse outcomes in patients with stable coronary artery disease: A meta-analysis.
Li T; Chen Y; Ye T; Zheng L; Chen L; Fan Y; Lin B
Atheroscler Plus; 2022 Jan; 47():1-7. PubMed ID: 36643602
[TBL] [Abstract][Full Text] [Related]
18. Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION Study.
Sharma A; Stevens SR; Lucas J; Fiuzat M; Adams KF; Whellan DJ; Donahue MP; Kitzman DW; Piña IL; Zannad F; Kraus WE; O'Connor CM; Felker GM
JACC Heart Fail; 2017 Oct; 5(10):724-734. PubMed ID: 28958347
[TBL] [Abstract][Full Text] [Related]
19. Major Adverse Cardiovascular Events and Mortality Prediction by Circulating GDF-15 in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Xie S; Li Q; Luk AOY; Lan HY; Chan PKS; Bayés-Genís A; Chan FKL; Fung E
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883490
[TBL] [Abstract][Full Text] [Related]
20. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
Anand IS; Kempf T; Rector TS; Tapken H; Allhoff T; Jantzen F; Kuskowski M; Cohn JN; Drexler H; Wollert KC
Circulation; 2010 Oct; 122(14):1387-95. PubMed ID: 20855664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
